SenesTechSNES
Recorded

SenesTech 2026 Q3 Earnings Call

Review the key takeaways and the transcript of this earnings call.

PeriodQ3 2026Duration1 hr 3 minParticipants8

Transcript

Preview the first fifteen paragraphs, organized by speaker.

Operator

Please also note today's event is being recorded. I would now like to turn the floor over to Robert Blum with Lytham Partners. Please go ahead. All right.

Robert BlumManaging Partner

Thank you very much, and thank you all for joining us today to discuss SenesTech's third quarter 2026 financial results. This is for the period ended September 30, 2026. With us on the call today is Michael Edell, the company's President and Chief Executive Officer, and Tom Chesterman, the company's Chief Financial Officer. As the operator mentioned, at the conclusion of today's prepared remarks, we will open the call up for questions. If you're dialed in through the traditional teleconference line, please press star, then one, as the operator indicated. If you are listening through the webcast portal and would like to ask a question, you can submit it through the Ask a Question feature in the webcast player. Before we begin, we'd like to remind everyone that our remarks today may include forward-looking statements.

Robert BlumManaging Partner

Statements made by the management team of SenesTech during the course of this conference call may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements describe future expectations, plans, results, or strategies, and are generally preceded by words such as may, future, plan or planned, will or should, expected, anticipates, draft, eventually, or projected.

Robert BlumManaging Partner

Listeners are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risk that actual results may differ materially from those projected in the forward-looking statements as a result of various factors and other risks identified in our filings with the Securities and Exchange Commission. All forward-looking statements contained during this conference call speak only as of the date in which they were made and are based on management's assumptions and estimates as of such date. Except as required by law, the company does not undertake any obligation to update any forward-looking statements, whether the results of the receipt of new information, the occurrence of future events, or otherwise. We will also discuss adjusted EBITDA, a non-GAAP financial measure.

Robert BlumManaging Partner

This measure should be considered alongside our GAAP results. A reconciliation to the most directly comparable GAAP measure is included in today's earnings release, available on the investor relations portion of our website. With that said, I will turn the call over to Michael Edell.

Michael EdellPresident and CEO

Michael, please go ahead. Thank you, Robert, and thank you to everyone joining us today.

Michael EdellPresident and CEO

This was a milestone quarter for SenesTech. We surpassed $1 million in quarterly revenue for the first time in our history, delivered our second consecutive quarterly revenue record, and set new records for gross profit and subscription customers. We are reaching more customers, building more ongoing relationships, and seeing the commercial opportunity for rodent birth control take shape across both consumer and professional markets. Revenue reached approximately $1.1 million, growing 42% from the second quarter and 59% from a year ago. Gross profit reached a record $796,000, and combined subscription customers across Amazon and our website increased 72% in just one quarter. Those results give us a great deal to be excited about as we build a larger business with a growing recurring revenue base.

Michael EdellPresident and CEO

On our last call, we discussed the opportunity to turn our e-commerce momentum into a broader platform for growth. This quarter, we made meaningful progress on that opportunity. Amazon continued to expand, our subscription base grew substantially, and our direct B2B business delivered sequential growth as we added sales capacity. Each of these areas plays an important role in where we go from here. Let me start with e-commerce. Revenue across our online channels increased 52% sequentially and 337% year-over-year, representing 71% of total third-quarter revenue. These channels serve both consumers and business customers. They make it easier for customers to discover our products, understand how rodent birth control fits their needs, and establish a regular purchasing routine. Amazon was again a major driver. Revenue increased 76% from the second quarter, and we established new quarterly records for orders, revenue, Subscribe & Save revenue, and subscribers.

Michael EdellPresident and CEO

Revenue increased every month of the quarter. That sustained progress is particularly encouraging because it shows the opportunity to build on the demand we are generating. When we decide where to invest next, we look at pricing, advertising costs, and the mix of channels where customers buy. We closely monitor acquisition cost, which helps us direct our advertising dollars toward customers we can serve profitably over time. That sustained progress is particularly encouraging because it shows the opportunity to build on the demand we are generating. We are focused on the full customer relationship, from the first time someone learns about Evolve to the decision to purchase again. Rodent population management is an ongoing need. Helping customers understand the value of a sustained approach is central to how we market our products and support their use.

Michael EdellPresident and CEO

Subscriptions bring that approach into purchasing experience by making replenishment more convenient, helping customers keep enough product on hand for the consistent use that effective rodent birth control requires. Amazon Subscribe & Save subscribers increased 161% from the end of June to the end of September. Across Amazon and our website, subscription revenue grew 53% sequentially and 234% year-over-year. Our combined subscriber base increased 72% during the quarter, and subscription revenues were approximately 15% of total e-commerce revenues. For us, this is one of the most exciting developments in the business. Every ongoing customer relationship creates an opportunity to build repeat purchasing and greater revenue visibility. We are investing in customer education, acquisition, and retention with that long-term relationship in mind. Our own website remains an important part of this effort, giving customers another direct way to learn about our products, buy them, and subscribe.

Michael EdellPresident and CEO

We are also broadening our reach through third-party e-commerce. The addition of Grove Collaborative brings Evolve to a highly engaged audience of sustainably focused consumers. It gives us another channel to introduce rodent birth control to customers who are actively looking for products that align with their priorities. To support the next stage of our brand and marketing work, we have engaged Sandstrom Partners as a strategic advisor. This Portland-based brand development firm has worked with brands including Nike, Target, and Coca-Cola, to name a few. Our work with Sandstrom Partners is another element of our growth strategy. The focus is on sharpening our brand identity and creating a clearer, more consistent way to communicate how and why our products work across consumer, B2B, and the investor audiences. From an investor perspective, we view stronger brand positioning as a commercial tool rather than simply a marketing exercise.

Michael EdellPresident and CEO

The objective is to build awareness and brand affinity, improve customer retention and acquisition, and support more effective sales and marketing across e-commerce and B2B channels. Sandstrom's work will also help us better define target audiences and value propositions and improve how customers discover and understand our products. Ultimately, the goal is to translate a differentiated product and stronger brand identity into sustainable sales growth, recurring customer relationships, and greater long-term value as we scale. We are very excited about the growth potential, leveraging the foundation we have built over the last six months. Amazon is bringing new customers to SenesTech. Subscriptions are turning more of those first purchases into ongoing relationships, and channels such as walmart.com and Grove are expanding our reach.

Michael EdellPresident and CEO

As we move through the fourth quarter, our focus is on building on that momentum by attracting more customers, keeping them engaged, and making repeat purchasing a natural part of their rodent management routine. We believe that combination can make e-commerce an even more powerful driver of sustained growth for SenesTech. Let me turn to direct B2B, which we see as the significant driver of growth alongside e-commerce. Direct B2B revenue increased 19% sequentially as changes to our sales process helped drive growth in our pest management, commercial, and government verticals. We are building the sales capacity to pursue these opportunities with greater focus and more consistent follow-through. Under Jack Karabees, our Executive Vice President of Sales, we now have four salespeople, including two recent additions. We expect to add at least one more before the end of the year.

Michael EdellPresident and CEO

This gives us more resources to best cover the number of territories in the U.S. to engage prospective customers, develop opportunities in our targeted vertical markets, and build repeat business. Our goal is to turn growing awareness into practical adoption. For a business or municipality, that means understanding the site, explaining where our products fit within its rodent management program, and supporting an ongoing approach. The expanded team gives us a greater capacity to have those conversations, develop those relationships, and build the pipeline. In July, we began deploying assessment and monitoring services across our targeted B2B verticals. These services help customers measure rodent activity and understand the scope of an infestation before we recommend a solution. Customers can choose a turnkey assessment performed by SenesTech or deploy our tracking products themselves with the data analyzed using our internally developed AI analysis tools.

Michael EdellPresident and CEO

These services also help us to reduce the sales cycle and increase the potential of each and every opportunity. Together with our existing implementation and deployment services, assessments give us another way to support customers throughout their rodent management programs and create additional revenue opportunities. The connection between e-commerce and B2B is important to understand. As more customers discover Evolve and become familiar with rodent birth control, we believe that awareness can support our direct sales effort. We have an opportunity to build a recognizable brand while developing deeper relationships with professional and municipal buyers. The municipal results we recently announced provide compelling examples of how our products can fit into integrated pest management programs. In Chicago's Wicker Park-Bucktown deployment, a program incorporating our assessment services and Evolve reduced average rodent activity intensity by 88% over 12 months. Rodent-related 311 calls in the area declined 36%.

FULL TRANSCRIPT

Continue the full translated transcript in StockNow.

Log in to unlock every statement, the English original, and speaker-by-speaker history.

Log in for the full transcript

Other earnings calls that day

View calls from this day